Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 473 All time
- Disclosed funding
- $19.6B 400 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| S SkinBitCompany profile Provides full-body skin scanning technology for early skin cancer detection and screening Provides full-body skin scanning technology for early skin cancer detection and screening | $6M | Pre-SeedPre-seed | Biotech, Healthtech | United States | Investors | |
| M MironidCompany profile Mironid develops small-molecule medicines for inherited kidney disease, with a lead programme targeting autosomal dominant polycystic kidney disease. Mironid develops small-molecule medicines for inherited kidney disease, with a lead programme targeting autosomal dominant polycystic kidney disease. | $46M | Series B | Biotech | United Kingdom | Investors | |
| LT LifeMine TherapeuticsCompany profile Develops fungal genome-derived therapeutics for organ transplant rejection Develops fungal genome-derived therapeutics for organ transplant rejection | $263M | Series D+Series EUndisclosed | Biotech | United States | Investors | |
| VB Vedanta BiosciencesCompany profile Develops microbiome-based oral therapies for prevention of recurrent C. difficile infection Develops microbiome-based oral therapies for prevention of recurrent C. difficile infection | $60M | Growth | Biotech | United States | Investors | |
| Q QuantHealthCompany profile AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment | $45M | Series B | Biotech | Israel | Investors | |
| CL CND Life SciencesCompany profile Develops biomarker-based diagnostic tests for neurodegenerative diseases Develops biomarker-based diagnostic tests for neurodegenerative diseases | Undisclosed | Growth | Biotech | United States | Investors | |
| C Uses genomic surveillance to identify hospital infection outbreaks and sources | $3.5M | Pre-SeedPre-seed | Biotech | United States | Investors | |
| I Whole-genome sequencing and bioinformatics platform for precision oncology | $31M | Series B | Biotech | United States | Investors | |
| DB Dash BioCompany profile Dash Bio provides automated bioanalysis for preclinical and clinical drug testing. Dash Bio provides automated bioanalysis for preclinical and clinical drug testing. | $30M | Series A | Biotech | United States | Investors | |
| RT Developing best-in-class radiopharmaceuticals for cancer treatment | $70M | Series CSeries C+ | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →